Clinical Trials Directory

Trials / Sponsors / iOnctura

iOnctura

Industry · 6 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study of Roginolisib in Combination With Ruxolitinib in Patients With Myelofibrosis (MF) Who Are Unresponsiv
Myelofibrosis (MF)
Phase 1 / Phase 22025-11-17
Active Not RecruitingA Study of Roginolisib (IOA-244) in Combination With Dostarlimab With or Without Docetaxel in Metastatic Non S
Non-Squamous Non-Small Cell Lung Cancer (NSCLC), Advanced Non Squamous NSCLC
Phase 1 / Phase 22025-04-22
Active Not RecruitingA Randomised Phase II Study of Roginolisib in Patients With Advanced/Metastatic Uveal Melanoma
Uveal Melanoma, Ocular Melanoma
Phase 22025-02-27
CompletedA Study to Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic Cancer
Metastatic Pancreatic Cancer
Phase 1 / Phase 22022-10-10
CompletedA Study to Assess an ATX Inhibitor (IOA-289) in Healthy Volunteers
Healthy
Phase 12021-06-28
Active Not RecruitingA Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers
Solid Tumor, Adult, Non-Hodgkin Lymphoma, Adult, NSCLC
Phase 12020-02-25